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1. INTRODUCTION
Recent developments in biotechnology involve
production of materials like vaccines, recombinant proteins,
monoclonal antibodies, etc. Demand for these biological
products has increased because they have been used for
therapeutic and diagnostic purposes. The key component
for the commercial success of any biopharmaceutical product
is the ability to achieve large-scale manufacture. The ultimate
goal of recombinant fermentation research is the cost-
effective production of desired protein by maximising the
volumetric productivity, i.e., to obtain highest amount of
protein in given volume in least period of time. Such bio-
processing for recombinant protein using genetically modified
organism requires a stable high-yielding recombinant culture,
a high productive fermentation process and cost-effective
recovery and purification procedures.  Escherichia coli
has been most widely used as host for the expression of
recombinant proteins1-4.
   Enormous data are available on advantages of using
E. coli as expression system, its cell biology, fermentation
process development and its ability to produce large quantities
of recombinant proteins in an inexpensive way. In past
20 years, recombinant DNA technology has enabled to
produce huge quantities of therapeutic proteins that might
otherwise have been difficult to produce. Recombinant
protein expression using E. coli as host is frequently
associated with the formation of intracellular aggregates
as inclusion body5. The volumetric yield of the protein
is thus a function of both unit cell concentration and
specific cellular protein yield. Optimisation of high cell
density fed-batch fermentation process is thus one of the
key steps for enhancing the volumetric yield of recombinant
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High cell density fermentation is a major bio-process
engineering consideration for enhancing the overall yield
of recombinant proteins in E. coli. Understanding of basic
biological aspect of the expression system at molecular
level and translating this information at process level is
imperative for efficient and cost-effective production of
therapeutic compound. While maintaining a stable plasmid
of interest, parameters that influence the high cell density
fed-batch aerobic growth of E. coli have been analysed8.
Novel ways of fed-batch fermentation process considering
most of these factors have been discussed in detail to
maximise the volumetric yield of recombinant proteins expressed
as inclusion body in E. coli. The selection of a particular
expression system requires a cost breakdown in terms of
process, design, and other economic considerations. The
advantages of E. coli have ensured that it remains a valuable
organism for the high-level production of recombinant
proteins9-10. Fed-batch processes have most often been
used to obtain high cell density11-15. Cell concentrations
of about ~100 g dry cell weight per litre can be yielded
by fed-batch culture of both non-recombinant and recombinant
E. coli16-18. However, this technique has several drawbacks,
including substrate inhibition, limited oxygen transfer capacity,
the formation of growth inhibitory by-products, and limited
heat dissipation.
Several feeding strategies have been used for increasing
cell concentrations in recombinant cultures, such as constant
feed, step-wise increase in feed, feeding based on a feedback
control technique so as to keep the dissolved oxygen or
pH constant and exponential feed18,19-23. Exponential feeding
is widely used so that the cells can be grown at the desired
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specific growth rate, preventing the formation of toxic by-
products like acetate24-27. The feeding method to maintain
the desired specific growth rate is fairly simple and amenable
to feed-forward control using substrate balance equations28.
Recombinant E. coli can be grown to high densities
in common media such as Luria broth (LB) 29-31, synthetic
M9 minimal medium32, Terrific broth (TB) 32-34 and Super
broth (SB) 35-37. The bacterium is generally grown under
aerobic conditions because anaerobic growth provides
less energy for metabolic processes such as protein synthesis38.
To ensure that oxygen supply does not become limiting,
the fed-batch operation is used extensively in cultures20,25.39.
This improves biomass and recombinant protein yield relative
to batch culture. Fed-batch operation overcomes possible
limitations due to a high concentration of substrate and
enables growth to be prolonged in comparison with traditional
batch fermentations. A major objective of fermentation
processes is to maximise the volumetric productivity. High
cell density cultures are the first step to achieve this goal.
The objective of the present review is to emphasise on
the importance of high productive fermentation of recombinant
proteini in E. coli. General scheme for large-scale fermentation
process is shown in Fig. 1. Some commonly used therapeutic
products and their manufacturers are shown in Tables 1
and 2.
2. Escherichia  Coli  EXPRESSION  SYSTEMS
In the industry, the selection of the host cell will be
strongly influenced by the type and use of the product,
as well as economic or intellectual property issues. A number
of new, sophisticated host-vector combinations have become
available in recent years. However, their use in commercial
applications lags behind. The T7-based pET (Novagen)
expression system38 with more than 40 different pET plasmids
available commercially is, by, far the most used in recombinant
protein preparation.Systems using the lPL promoter/cI
repressor (e.g., Invitrogen pLEX), Trc, Tac promoter (e.g.,
GE pTrc, pGEX), araBAD promoter (e.g., Invitrogen pBAD)
and hybrid lac/T5 (e.g., Qiagen pQE) promoters are common.
E. coli K12 derivatives are most widely used, often with
protease-deficiencies and other mutations. Recently, B strains,
e.g. BL21, gained in popularity due to their efficiency in
recombinant protein expression3,4. Further  developments
make the use of E. coli even more attractive due to product
secretion (e.g., recombinant peptide) to the extracellular
space39.
Different E. coli B and K12 strains are the main work
horses for expressing non-glycosylated peptides and proteins
at research level and in the industry. E. coli is genetically
well characterised and efficient expression of recombinant
product to more than 50 percent of total cell mass has been
reported40. The selection and design of the expression
plasmids influence synthesis rates, plasmid copy number,
the segregational plasmid stability and therefore productivity
and regulatory issues. For industrial applications, selective
pressure by antibiotics is mainly maintained in pre-cultures;
main cultures are usually grown without selective pressure.
 
Harvest cells 
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Purify Product 
Stock culture 
Purify Product 
Figure 1. General scheme for large-scale fermentation
process.
Product Brand name Company 
Insulin Wosulin Wockhardt 
Insulin  Insugen Biocon 
Erythroprotein Hemax Hindustan Antibiotics 
Erythroprotein Wepox Wockhardt 
Erythroprotein Ceriton Ranbaxy 
Erythroprotein Shanprotein Shantha Biotechnics 
Hepatitis B vaccine Shanvac B Shantha Biotechnics 
Hepatitis B vaccine Revac B Bharat Biotech 
Hepatitis B vaccine Enivac HP Panacea Biotech 
Hepatitis B vaccine Biovac Wockhardt 
Hepatitis B vaccine Gene Vac-B Serum Institute 
Hepatitis B vaccine Bevac Biological E 
Streptokinase Indikinase  Bharat Biotech 
Streptokinase Shankinase Shantha Biotechnics 
Streptokinase STPase Cadila Pharmaceuticals 
Interferon a-2b Shanferon Shantha Biotechnics 
Table 1. List of some therapeutics and their manufactures
in India
139
TRIPATHI, et al.: PRODUCTION OF RECOMBINANT PROTEINS WITH E. COLI
The ideal expression vector combines medium-to-high copy
numbers with tight regulation of gene expression to achieve
rapid cell growth to high densities before the induction
phase8,41.
3. FERMENTATION
Protein production in E. coli can be increased significantly
using fermentor culture systems, which can be classified
into three groups: batch, fed-batch, and continuous1,42-43.
These methods can achieve cell concentrations about 100
g/l of dry cell weight and can provide cost-effective production
of recombinant proteins. The development and design of
fermentation process and fermenter itself play a key role
for achieving productivity and robustness at scale up44.
3.1. High Cell Density Fermentation
High cell density culture (HCDC) techniques for culturing
E. coil have been developed to improve productivity, and
also to provide advantages such as reduced culture volume,
enhanced downstream processing, reduced wastewater,
lower production costs and reduced investment in equipment.
High cell density culture systems also suffer from several
drawbacks, including limited availability of dissolved oxygen,
carbon dioxide levels which can decrease growth rates
and stimulate acetate formation, reduction in the mixing
efficiency of the fermentor, and heat generation16-17,40,44.
A major challenge in the production of recombinant protein
at high cell density is the accumulation of acetate, a lipophilic
agent that is detrimental to cell growth. A number of strategies
have been developed to reduce acetate formation, but
these suffer from several drawbacks. This problem was
resolved through the metabolic engineering of E. coli45.
The reduction in acetate accumulation caused a significant
improvement in the production of recombinant protein46.
Mutant strains of E. coli that are deficient in other enzymes
have also been developed and shown to produce less
acetate and higher levels of recombinant proteins47.
In high cell density fermentation, maximising cell
concentration helps in increasing the volumetric productivity
of recombinant proteins. For example, optical density of
about 124 resulted for high cell density culture for production
of recombinant ovine growth harmone in E. coli40. It is
also essential that cell growth be achieved in optimal time
period to improve the overall production of the recombinant
protein. Toxicity of acetate, slow growth rate, instability
of plasmid, depletion of amino acid pools to sustain high
rate of protein synthesis affect the specific cellular yield
of recombinant protein at high cell concentration48-50. It
is expected that by analyzing all these parameters during
high cell density fed- batch growth of E. coli will lead
to high volumetric production of the desired protein.
3.2. Important Parameters Affecting Fermentation
Process
The operating condition such as pH, temperature and
more importantly O2 supply is very essential for supporting
high cell growth. Solubility of oxygen in medium is very
low and with increase in cell concentration during fed-
batch growth, the solubility is reduced. At very high cell
concentration use of air does not suffice the respiratory
demand of the rapidly growing E. coli cells51-52. Increasing
aeration rate, feeding O2- rich air, decreasing temperature,
increasing partial pressure of the culture vessel are some
of the methods employed to maintain aerobic condition
during cell growth53. It has been widely documented that
oxygen not only influences the cell growth but also has
effect on gene expression by influencing the oxidative
status of many enzymes20,54. Hence it is essential that
Product Company 
Asparaginase  Merck 
r Cholera toxin B subunit  SBL Vaccine 
rh B-type natriuretic peptide  Scios/Johnson & Johnson 
Tissue plasminogen activator  Roche 
rh Insulin  Eli Lilly, Aventis 
rh Growth hormone  Genentech, Eli Lilly  
h Parathyroid hormone  Eli Lilly 
rh Interferon a-2a and 2b Hoffmann-LaRoche, Schering 
Interferon alfacon-1  Valeant 
r IL-2-diphtheria toxin fusion Seragen / Ligand 
rh IL-1 receptor antagonist  Amgen 
r IL-2  Chiron 
r Interferon b -1b  Schering AG, Chiron 
r Interferon g-1b  Genentec 
 
Table 2. List of some therapeutics with their heterologous expression
host E. Coli and their manufactures abroad
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along with proper feeding of nutrients, supply of oxygen
should be at optimal level to support good growth and
provide oxidising environment for quality protein
synthesis19,55-57.
Composition of medium, physical parameters during
growth and operating conditions are the most important
factors that influence the cell growth. Limitation and or
inhibition of substrates, limited capacity of oxygen supply,
formation of metabolic byproducts, and instability of plasmid
during long hours of cultivation, are the most common
problems encountered during high cell density growth of
E. coli44,46,58. These, most of the time depend on host
strain, vector, and strength of promoter. Dense culture
requires large amounts of O2 to support good growth and
thus necessitates unconventional aeration strategy to maintain
dissolved O2 concentration at a suitable level throughout
the growth period.  In most of the cases of E. coli being
used as a host for recombinant protein, the production
phase start after induction with suitable inducer8,40. Thus
in principle, growth phase and production phase can be
delineated in the same vessel for the high volumetric yield
of the recombinant protein. However many a times, operation
of reactor during cell growth influences the specific yield
of the recombinant proteins. Thus while developing fed-
batch operation to increase unit cell growth in the reactor
it is alsoy essential to take care of the factors which affect
the specific yield of the recombinant protein.
3.3. Development of Growth Media
The composition of the cell growth medium must be
carefully formulated and monitored, because it may have
significant metabolic effects on both the cells and protein
production. For example, the translation of different mRNAs
is differentially affected by temperature as well as changes
in the culture medium59. Chemically defined media are generally
known to produce slower growth and low protein titres
than the complex media33. Nonetheless, use of chemically
defined media in producing recombinant proteins is a common
practice60-63 because these media attain more consistent
titres, allow easier process control and monitoring, and
simplify downstream recovery of the target protein.
Nutrient composition and fermentation variables such
as temperature, pH, and other parameters can affect proteolytic
activity, secretion, and production levels47.
Specific manipulations of the culture medium have
been shown to enhance protein release into the medium.
Thus, supplementation of the growth medium with glycine
enhances the release of periplasmic proteins into the medium
without causing significant cell lysis45. Some nutrients,
including carbon and nitrogen sources, can inhibit cell
growth when these are present above a certain concentration.
This explains why just increasing the concentrations of
nutrients in batch culture medium does not yield high cell
density. Among the three types of media defined, complex
and semi-defined; defined media are generally used to
obtain high cell density, as the nutrient concentrations
are known and can be controlled during culture. However,
semi-defined or complex media are sometimes necessary
to boost product formation.  To grow cells in a high density,
it is necessary to design a balanced nutrient medium that
contains all the necessary components in supporting cell
growth, avoiding inhibition. It is desirable to make the
feed-solution as simple as possible by including sufficient
non-carbon and non-nitrogen nutrients in the starting
medium. One of the essential requirements during fed-
batch operation is to supply nutrients to promote cell
growth18,40. To limit their toxicity to the growing cells nutrients
such as glucose, ammonia, salt are fed approximating their
requirement.
Accumulation of nutrients at high concentration inhibits
growth and recombinant protein expression7. High glucose
causes Crabtree effect and leads to accumulation of acetate
which is inhibitory to cell growth40. In general, most of
the media used for high cell growth of E. coli have carbon
source, mostly glucose; major salts like phosphate, sodium,
potassium, magnesium, ammonia and sulphates, iron; minor
trace elements and complex nitrogenous compounds. High
density growth in general is initiated with low concentration
of the most required substrate and the nutrients are added
later in the growth period5,23. Ideally, components should
be added to the fermenter at the same rate at which these
are consumed, so that it prevents the nutrient accumulation
in toxic levels while promoting good growth. Another factor
which needs attention during medium formulation is the
solubility of many components, particularly while making
concentrated solution for fed-batch addition. High
concentration of glycerol, glucose, yeast extract, and trace
elements needs careful composition to avoid precipitation.
3.4. Accumulation of Acetate during Fermentation
Process
Acetic acid secretion during aerobic growth of E. coli
is a major constraint of high productivity recombinant
fermentation process. E. coli excrete 10-30 per cent of the
carbon flux from glucose to acetate during its aerobic
growth on glucose. Acetic acid decreases both biomass
and the expected cell densities. Inhibition of acetate is
significant for cells cultured in a defined medium than a
complex medium. Inhibitory effect of acetic acid on growth
of E. coli cells affecting the volumetric productivity of
recombinant proteins during high cell density fermentation
has been widely documented1,26-27. Acetate is produced
when E. coli is grown under anaerobic or oxygen-limiting
conditions; however, E. coli cultures growing in the presence
of excess glucose can also produce acetate even under
aerobic conditions. A high concentration of acetate (> 5
g/l at pH 7) reduces growth rate, biomass yield, and maximum
attainable cell densities in HCDC.  In general, acetate
formation is dependent on the medium used and the specific
growth rate. The acetate is formed in complex and defined
medium when the specific growth rate exceeds 0.2 h-1
or 0.35 h-1, respectively. A study with a different E. coli
strain showed that acetate was produced in a defined
medium when the specific growth rate16,40,46 was higher
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than 0.14 h -1. Therefore, the critical specific growth rate
that leads to acetate formation varies among strains and
depends on the medium used.  The production of acetate
is greater in fed-batch cultures than in batch cultures
owing to the extended culture period. Acetate formation
can also be reduced or prevented by altering the formulation
of the medium. Acetate is not produced when glycerol is
used as a carbon source16-17,34,64 as well as high cell densities
might be achieved relatively easily.
Acetate accumulation affects the substrate utilisation,
inhibits cell growth and recombinant protein production,
and then it needs special attention during the development
of fed-batch fermentation process. A number of strategies
have been adopted to reduce the acetate accumulation
during high cell density fed-batch cultivation of E. coil.
Most of the strategies have been based on decreasing
anabolic requirements in terms of reducing glucose uptake
or increasing the oxidative metabolic capacity26,65. Controlling
specific growth rate by manipulation of nutrients or nitrogen
source have also been tried to reduce the acetate formation23,40.
Alternatively, the use of dialysis reactor, which facilitates
the removal of acetate from the culture broth,66 can reduce
the inhibitory effect of acetate. Genetic engineering techniques,
use of fructose as an alternate carbon source, and selection
of low-acetate producing strains have been successfully
tried to lower the secretion of acetic acid during aerobic
growth of E. coli. Accumulation of acetate during E. coli
fermentation is the net result of its formation and uptake
by the cells26. It’s thus essential to control the formation
of acetate and enhance its uptake to maintain low level
of acetate during fed-batch growth of E. coli.
3.5 Effect of Yeast Extract during Fermentation
Process
It has been observed that addition of yeast extract
not only helps in reducing secretion of acetic acid during
growth of E. coli, but also helps in utilisation of acetic
acid during carbon limitation. Apart from this, organic
nitrogen source like yeast extract and soybean hydrolysate
have been reported to enhance the specific cellular yield
of the expressed protein, particularly during high cell density
fermentation where the demand of nitrogenous source
becomes very high following induction30,60. The use of
yeast extract along with glucose feeding helped in maintaining
a higher growth rate during fermentation with very little
acetic acid secretion. Presence of yeast extract in the
medium provides nutrients and precursors for synthesis
of building blocks of cells and thus glucose is used mainly
as an energy source. Presence of yeast extract in the
medium also helps in lowering the inhibitory effect of
acetic acid and also works as a better physiological buffer
in comparison to the minimal medium7,34,64. Therefore, its
use in the feeding medium along with glucose helped in
avoiding the need of complex genetic manipulation to
lower the acetic acid secretion5. This indicates that with
the use of yeast extract in the feeding medium not only
the specific yields of protein can be maintained in high
cell density fermentation but also the duration of the process
can be reduced, resulting in high volumetric productivity
of the expressed protein.
3.6 Feeding Strategy during Fermentation Process
Feeding of nutrient is critical to the success of HCDC,
as it not only affects the maximum attainable cell concentration,
but also cell productivity60. The use of fed-batch cultures
has been shown to significantly increase the cell density
and specific protein production by overcoming inhibitory
substrate concentrations encountered in batch culture19-
20,31,55
. Various strategies exist for controlled feeding of
fed-batch cultures. A pH-stat feeding system monitors the
pH of the fermentation for indications of acetic acid
production6,13. The feed rate is increased until the maximum
growth rate is reached as indicated by a metabolic overflow
causing production of acid and a consequent decrease
in pH25,38. The DO-stat operation relies on the fact that
specific oxygen uptake reaches a maximum at the maximum
growth rate6,13,28.  Changes in oxygen uptake rate following
a pulse of feed are used to determine whether the
microorganism is at its maximum growth rate25.
Exponential feeding makes use of an empirical model
of growth, to regulate the feed rate6,12.  One of the essential
requirements to obtain good cell growth during cultivation
is to supply nutrients in a manner that is desirable. Ideally,
by providing proper nutrient and operating conditions,
exponential growth of E. coli can be maintained so that
high cell concentration is achieved in less time. Oxygen
supply, saturation of the oxidative capacity of cells at
high glucose concentration, build-up of acetate to toxic
level, plasmid instability, and low productivity associated
with cell growth at high specific growth rate, has led to
the development of different feeding strategies to achieve
high cell growth in a reasonable time period19,50,57,65.
Direct feedback control is also possible by measuring
online concentration of the growth-limiting substrate in
the culture broth and adjusting the concentration to the
preset value by automatic feeding. The feeding solution
is added either simply in a constant way or by an exponential
feeding programme. Two points are important to guarantee
a good yield: (a) the flow of the feed solution must be
low enough to allow glucose limitation in the fermenter;
(b) the flow of the feed solution must be regulated in a
way that the specific growth rate does not come below
0.1 h–1 until the point of induction5.
3.7 Plasmid Stability during Fermentation Process
One of the most important factors that affect the
expression of recombinant protein from E. coli is the
maintenance of the plasmid within the host cells8. High
cell density growth of E. coli in fed-batch mode needs
longer time and more generation number for cultivation
in comparison to normal shaker flask culture. Because of
this, plasmid instability problems are serious in large-
scale culture6,8,44.  It is thus essential to have host/vector
system as well as cultivation conditions that promote
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better plasmid stability during high cell density cultivation.
Even though in many cases, the antibiotic pressure is
used to overcome plasmid instability, the stability of antibiotic67
solution during long cultivation period should be taken
into consideration. Most of the antibiotics have very short
half-life (e.g., Pencillin G or Tetracycline t1/2 between 5.6
h and 15.2 h)67 and it is thus essential to supply them
throughout the cultivation period intermittently so the
high plasmid stability is maintained during the fed-batch
cultivation period4,58. Apart from these novel vectors such
as run away replication vector (pURA-4) 68, vectors having
self-destroying properties of killing plasmidless cells, such
as using hok/sok sequences, can be used to overcome
the plasmid instability problems69. Use of nutrient addition
and bioreactor configurations has improved plasmid stability
during high cell density fed-batch fermentation40,44,70.
3.8 Induction Strategy and Effect of Oxygen during
Fermentation Process
Cellular responses to induction depend on a number
of interacting factors including the host/vector system
and properties of the expressed protein. Therefore, the
timing of induction of new recombinants needs to be empirically
determined for each new clone61. Inducer concentration
trials are required since IPTG inducer is expensive. The
concentration of IPTG required for complete induction is
known to vary widely along with various clones expressing
different proteins35. The induction strategy needs optimisation
to maintain specific cellular protein yield during high cell
density fed-batch fermentation. Level of gene expression,
localisation of the expressed protein, its toxic effect, either
due to the gene product or due to high level accumulation
of the foreign protein and the product degradation
characteristics, decide the induction strategy. For chemical
inducer, the concentration of inducer is also important to
completely   de-repress the promoter to achieve maximum
protein expression during high cell density fermentation3,8.
Final synthesis of the protein depends upon the amino
acids, thus it is also important to see that the amino acid
pools of the host cells meet the demand during high level
synthesis of the foreign protein. In fed-batch culture,
separation of the two phases can be achieved by delaying
induction of the culture until the culture has completed
its growth to the required high densities. Considering
these aspects, it is essential to decide the induction time
so that both cell growth and specific yield are maximised
with the result in high volumetric yield of the protein.
In recent times, the secondary role of oxygen on
maintenance of cell physiology and quality of the recombinant
protein have been a major concern for the high volumetric
yield of recombinant protein from E. coli54,71.  Fluctuations
in oxygen content during high productive fermentation
process can cause oxidative stress within the cells, leading
to limitation in amino acid production, plasmid instability,
and more importantly, oxidation of proteins.  These effects
altogether may affect the quality of the final product.
Oxygen often becomes limiting in HCDCs owing to its low
solubility. The saturated dissolved oxygen (DO) concentration
in water at 25°C is ~7mg/l but oxygen supply can be
increased by increasing the aeration rate or agitation speed16.
Oxygen-enriched air or pure oxygen has also been used
to prevent oxygen limitation, as for example in high yield
production of recombinant malaria antigen and human
interferon18,21. However, pure oxygen is expensive and
increases production costs when used in large quantities.
As oxygen consumption increases with growth rate, the
oxygen demand of cells can be reduced by lowering the
growth rate.
3.9  Metabolic Loads
Some proteins directly influence host cellular metabolism
by their enzymatic properties, as the expression of recombinant
proteins induces a metabolic burden. The metabolic burden
is defined as the amount of resources (raw material and
energy) that are required to be withdrawn from the host
metabolism for maintenance and expression of the foreign
DNA72. In general, the specific growth rate of cells expressing
a product correlates inversely with the rate of recombinant
protein synthesis73. The expression of recombinant proteins
therefore, usually results in impaired growth rates and
lower increase in biomass. This is a direct response to
the high energy requirements induced by recombinant
protein synthesis, synthesis of stress proteins, and elevated
respiration rates73. Recombinant expression results in high
rates of protein synthesis. However, while the recombinant
protein is highly expressed, housekeeping genes, including
components of the protein synthesis machinery, are down
regulated72. Amino acid starvation tends to occur during
recombinant expression, if the product deviates considerably
from the average E. coli protein. If the desired quality and
quantity of recombinant protein is impaired, stress situations
should clearly be avoided and circumvented.
4. SCALE-UP  OF  FERMENTATION  PROCESS
Recombinant microorganisms are usually cultivated
at several cubic meter scale and fed-batch operations have
made high cell density fermentations possible, thus increasing
the productivity of bioprocesses significantly. A common
problem with large-scale protein production is the metabolic
overload and stress, since plasmid maintenance and
heterologous protein expression are the burden upon the
host cell. A robust and efficient aerobic fermentation process
requires intense process development and tight control
of process parameters such as carbon source concentration,
temperature, pH and dissolved oxygen58,74-75.
To increase product yields and to ensure consistent
product quality key issues of industrial fermentations process
optimisation and scale-up are aimed at maintaining optimum
and homogenous reaction conditions, minimising microbial
stress exposure, and enhancing metabolic accuracy44,76.
Cells close to the injection port are exposed to high
concentrations of nutrients, whereas at other locations,
cells are starved of substrate4,70. Thus, it is important to
study the mixing patterns in a fermenter, and to find ways
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to improve mixing.  Therefore, the pressurised culture
regime used to increase oxygen transfer may also enhance
the detrimental effect of CO2. Heat generation can also
become a problem in HCDC, especially in large-scale
fermentations. These problems can be partially solved by
growing cells at a reduced specific growth rate. The problem
of reduced mixing quality in larger scales is aggravated
with increasing vessel sizes: the opposite substrate and
oxygen gradients along the vessel height, which are formed
as a result of the conventional  fermenter design according
to which substrate feed usually occurs from the top and
aeration from the bottom, are more pronounced in larger
reactors due to: (i) longer distances to be covered leading
to larger substrate and oxygen depletion zones, (ii)  larger
volumes of culture broth to be stirred and therewith longer
mixing times, and (iii) stronger hydraulic pressure gradients
influencing the oxygen-transfer rate74.
In case of glucose feeding, cells at the fermenter top
are exposed to excess glucose concentrations and
simultaneously suffer from oxygen imitations, whereas
those at the bottom are exposed to glucose starvation.
Excess glucose concentrations result in acetate overproduction
(overflow metabolism), a simultaneous oxygen limitation
further induces the formation of ethanol, hydrogen, formiate,
lactate, and succinate (mixed acid fermentation) 20,74.  Amino
acid misincorporations are thus a cause for an increase
in by-products at the expense of the desired main product
yields in larger scales.
Plasmid stability, an essential prerequisite for high
product yields particularly in larger scales, in which cultures
pass a higher number of generations due to larger culture
broth volumes and longer inoculation chains from the cell
bank to the production stage, is the stable propagation
of plasmids to daughter cells. Plasmid stability is influenced
by the plasmid properties70 as well as by process parameters
like temperature, growth rates and substrate concentrations.
Rapid glucose oscillations favour plasmid stability and
recombinant protein production rate, whereas high glucose
concentrations diminish plasmid stability65. Plasmid stability
and plasmid numbers are thus negatively influenced, more
difficult to control, and less easy to be maintained in
larger scales.  A prioritised goal of process optimisation
and scale-up thus consists of an appropriate process design
which improves the physiological conditions and the metablic
accuracy by minimising microbial stress exposure.
5. CONCLUSIONS  AND  FUTURE  CHALLENGES
Although many alternative organisms and expression
systems are now being used for recombinant protein production,
exciting progress continues to be made with E. coli.
Recombinant proteins in E. coli can be produced to high
yield by fed-batch culture. It is now relatively easy to
obtain high protein yield by controlling the acetate
concentration below the inhibitory level which allows the
control of the specific growth rate. While glucose or glycerol
serves as carbon sources, yeast extract, plant-derived
hydrolysates or peptones are usually employed as complex
nitrogen sources. Complex media components may be critical
since these provide a source for process variability. An
increasing number of recombinant protein diagnostics as
well as therapeutics will have to be produced in the years
to come.
Microbial expression systems, e.g. E. coli will aid in
efficient production of bio-pharmaceuticals. Major constraints
of high productive recombinant protein expression during
aerobic growth of E. coli are the secretion of acetic acid,
effect of medium, dissolved oxygen, lowering of the specific
cellular protein yield, etc. To avoid secretion of acetic
acid, cells are generally grown at lower specific growth
rates to achieve high cell concentration. Operation of fed-
batch fermentation at lower specific growth rate of E. coli
extends the duration of the batch time, and hence, affects
volumetric productivity of recombinant protein. Future
challenges in the use of E. coli for high level expression
will involve the following factors.
• The first one is the achievement of enhanced yields
of desired proteins by maintaining desired parameters,
viz., dissolved oxygen, pH, temperature, agitation, feeding
rate of nutrients.
• The second one is the utilisation of carbon and nitrogen
sources at controlled rates.
• It would be interesting to investigate, in the future,
if one has also to look for new alternative methods
to improve the overall yields and quality of desired
product economically.
• Another challenge is to overcome the drawbacks during
fermentation process.
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